These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 1323399)

  • 1. Clinical results with nimodipine in Alzheimer disease.
    Grobe-Einsler R; Traber J
    Clin Neuropharmacol; 1992; 15 Suppl 1 Pt A():416A-417A. PubMed ID: 1323399
    [No Abstract]   [Full Text] [Related]  

  • 2. [The use of nimodipine in elderly dementia patients].
    Damulin IV; Levin OS; Zakharov VV; Zhuchenko TD; Elkin MN
    Ter Arkh; 1995; 67(10):77-9. PubMed ID: 8779117
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Calcium channel blocker nimodipine for primary degenerative dementia.
    Jarvik LF
    Biol Psychiatry; 1991 Dec; 30(11):1171-2. PubMed ID: 1777531
    [No Abstract]   [Full Text] [Related]  

  • 4. In vivo morphine decreases [3H]nimodipine receptor binding in rat brain regions.
    Gandhi VC; Ross DH
    Neurochem Res; 1988 Dec; 13(12):1175-81. PubMed ID: 2853309
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nimodipine in the treatment of old age dementias.
    Ban TA; Morey L; Aguglia E; Azzarelli O; Balsano F; Marigliano V; Caglieris N; Sterlicchio M; Capurso A; Tomasi NA
    Prog Neuropsychopharmacol Biol Psychiatry; 1990; 14(4):525-51. PubMed ID: 2236581
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of kappa agonist U50-488H on [3H]nimodipine receptor binding in rat brain regions.
    Gandhi VC; Ross DH
    Eur J Pharmacol; 1988 May; 150(1-2):51-7. PubMed ID: 2841143
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Kainic acid lesions decrease striatal dopamine receptors and 1,4-dihydropyridine sites.
    Skattebøl A; Hruska RE; Hawthorn M; Triggle DJ
    Neurosci Lett; 1988 Jun; 89(1):85-9. PubMed ID: 2456499
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical findings with nimodipine in dementia: test of the calcium hypothesis.
    Fritze J; Walden J
    J Neural Transm Suppl; 1995; 46():439-53. PubMed ID: 8821080
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Global rating, symptoms, behavior, and cognitive performance as indicators of efficacy in clinical studies with nimodipine in elderly patients with cognitive impairment syndromes.
    Schmage N; Bergener M
    Int Psychogeriatr; 1992; 4 Suppl 1():89-99. PubMed ID: 1504290
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The importance of nimodipine in treatment of dementia].
    Eckert A
    Pharm Unserer Zeit; 2005; 34(5):392-8. PubMed ID: 16180362
    [No Abstract]   [Full Text] [Related]  

  • 11. Molecular basis for the inhibition of 1,4-dihydropyridine calcium channel drugs binding to their receptors by a nonspecific site interaction mechanism.
    Young HS; Skita V; Mason RP; Herbette LG
    Biophys J; 1992 May; 61(5):1244-55. PubMed ID: 1318093
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The molecular pharmacology and structural features of calcium channels.
    Ferry DR; Goll A; Rombusch M; Glossmann H
    Br J Clin Pharmacol; 1985; 20 Suppl 2(Suppl 2):233S-246S. PubMed ID: 2413875
    [No Abstract]   [Full Text] [Related]  

  • 13. Regional distribution of calcium channel ligand (1,4-dihydropyridine) binding sites and 45Ca2+ uptake processes in rat brain.
    Skattebøl A; Triggle DJ
    Biochem Pharmacol; 1987 Dec; 36(23):4163-6. PubMed ID: 2446630
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Visualization of nimodipine (NIM) binding sites of rat brain by means of a NIM-colloidal gold complex (1-2).
    Seitun A; Milintenda-Floriani F; Bonetti A
    Ital J Neurol Sci; 1991 Jun; 12(3 Suppl 11):63-7. PubMed ID: 1661714
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Mechanisms of action of Alzheimer medications].
    Alhainen K
    Duodecim; 2003; 119(20):1959-66. PubMed ID: 14640001
    [No Abstract]   [Full Text] [Related]  

  • 16. Effects of dihydropyridines on calcium release from the isolated membrane complex consisting of the transverse tubule and sarcoplasmic reticulum.
    Ohkusa T; Carlos AD; Kang JJ; Smilowitz H; Ikemoto N
    Biochem Biophys Res Commun; 1991 Feb; 175(1):271-6. PubMed ID: 1847807
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prolonged morphine treatment increases rat brain dihydropyridine binding sites: possible involvement in development of morphine dependence.
    Ramkumar V; el-Fakahany EE
    Eur J Pharmacol; 1988 Jan; 146(1):73-83. PubMed ID: 2832198
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dihydropyridine receptor in rat brain labeled with [3H]nimodipine.
    Bellemann P; Schade A; Towart R
    Proc Natl Acad Sci U S A; 1983 Apr; 80(8):2356-60. PubMed ID: 6300912
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ca(2+)-activated K+ channels in rat otic ganglion cells: role of Ca2+ entry via Ca2+ channels and nicotinic receptors.
    Callister RJ; Keast JR; Sah P
    J Physiol; 1997 May; 500 ( Pt 3)(Pt 3):571-82. PubMed ID: 9161976
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interaction of 1,4 dihydropyridine calcium channel antagonists with biological membranes: lipid bilayer partitioning could occur before drug binding to receptors.
    Herbette LG; Vant Erve YM; Rhodes DG
    J Mol Cell Cardiol; 1989 Feb; 21(2):187-201. PubMed ID: 2545886
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.